查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1555591

病人参与解决方案市场:全球产业分析，规模，占有率，成长，趋势，预测，2024-2033年

Patient Engagement Solution Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research最近发布了一份有关全球患者参与解决方案市场的详细报告。该报告对市场推动因素、趋势、机会和挑战等基本市场动态进行了详细分析，并对市场前景提供了宝贵的见解。

主要的洞察

  • 病患参与解决方案市场规模（2024 年）：213 亿美元
  • 预测市场规模（2033 年）：507 亿美元
  • 全球市场成长率（2024 年至 2033 年复合年增长率）：13.2%

病患参与解决方案市场 - 报告范围

病患参与解决方案是医疗保健领域的重要进步，专注于提高病患对自身照护的参与度。这些解决方案包括各种工具和技术，旨在促进患者和医疗保健专业人员之间的沟通、加强患者教育并改善整体医疗保健结果。该市场包括患者入口网站、行动健康应用程式和远端监控系统等平台。患者参与市场的成长是由对以患者为中心的护理的日益关注、数位医疗技术的进步以及改善医疗保健结果的需求所推动的。

推动市场成长的因素：

全球患者参与解决方案市场由几个关键因素推动，包括对个人化和以患者为中心的医疗保健服务不断增长的需求。远距医疗、行动医疗应用和穿戴式装置等数位医疗领域的技术进步正在提高患者参与度并推动市场扩张。对慢性病管理和预防性医疗保健的日益关注也有助于市场扩张，因为这些解决方案可以更好地监测和管理健康状况。此外，旨在改善病患照护和结果的政府措施和医疗改革进一步推动了病患参与解决方案的采用。

市场阻碍因素：

儘管市场成长潜力巨大，但病患参与解决方案市场仍面临资料安全、隐私保护和技术整合的挑战。确保病患资料的安全和隐私对于维持信任和遵守 HIPAA 等法规至关重要。将患者参与解决方案与现有医疗保健系统整合既复杂又昂贵，这对医疗保健提供者来说是一个挑战。患者群体在数位健康素养和技术取得方面的差异也可能阻碍这些解决方案的广泛采用。

市场机会：

由于技术创新和不断发展的医疗模式，患者参与解决方案市场提供了巨大的成长机会。将人工智慧 (AI) 和机器学习整合到患者参与平台中可以支援个人化护理和预测分析。也存在将这些解决方案扩展到服务不足和获得医疗服务可能有限的农村地区的机会。技术提供者、医疗保健组织和付款人之间的策略合作伙伴关係可以创造新的商业模式并推动市场成长。此外，对基于价值的护理和患者满意度的更多关注为开发创新的患者参与解决方案提供了机会。

本报告涵盖的主要问题

  • 推动全球患者参与解决方案市场成长的关键因素有哪些？
  • 哪些类型的患者参与解决方案在每个地区受到关注？
  • 技术进步如何改变病患参与市场的竞争格局？
  • 谁是病患参与解决方案市场的主要参与者？ 他们采取了哪些策略来维持市场影响力？
  • 全球患者参与解决方案市场的新趋势和未来前景是什么？

目录

第1章 摘要整理

第2章 市场概要

  • 市场范围/分类
  • 市场定义/范围/限制

第3章 主要市场趋势

  • 影响市场的主要趋势
  • 产品革新/开发趋势

第4章 价格分析

  • 各解决方案的价格分析
    • 订阅定价模式
    • 永久授权
  • 平均价格分析基准

第5章 全球病人参与解决方案市场的需求(金额:10亿美元)分析

  • 市场金额(10亿美元)分析，2019～2023年
  • 市场金额(10亿美元)预测，2024～2033年
    • 与前一年同期比较成长趋势分析
    • 绝对的商机

第6章 市场背景

  • 宏观经济要素
  • 预测要素- 相关性及影响
  • 价值链
  • COVID-19危机- 影响评估
  • 市场动态

第7章 病人参与解决方案的全球市场分析:各解决方案

  • 简介/主要调查结果
  • 各解决方案市场规模(10亿美元)分析，2019年～2023年
  • 各解决方案市场规模(10亿美元)分析与预测，2024～2033年
    • 软体
      • 整合的病人参与软体
      • 独立的软体
        • 计划管理软体
        • 申请软体
        • 安全的通讯软体
        • 其他
    • 服务
      • 与实行整合
      • 咨询
      • 支援和维修
  • 各解决方案市场魅力分析

第8章 病人参与解决方案的全球市场分析:各部署

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，各部署，2019年～2023年
  • 市场规模(10亿美元)分析与预测，各部署，2024～2033年
    • 云端
    • 内部部署
  • 各部署市场魅力分析

第9章 全球病人参与解决方案市场分析:各用途

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，各用途，2019年～2023年
  • 市场规模(10亿美元)分析与预测，各用途，2024～2033年
    • 健康管理
    • 社群管理
    • 家庭医疗保健管理
    • 财务健全性管理
    • 其他
  • 各用途的市场魅力分析

第10章 全球病人参与解决方案市场分析:各终端用户

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，各终端用户，2019年～2023年
  • 市场规模(10亿美元)分析与预测，各终端用户，2024～2033年
    • 患者
    • 付款者
    • 医疗保健提供者
    • 其他
  • 各终端用户市场魅力分析

第11章 全球病人参与解决方案市场分析:各地区

  • 简介/主要调查结果
  • 市场规模(10亿美元)分析，各地区，2019年～2023年
  • 市场规模(10亿美元)分析与预测，各地区，2024～2033年
    • 北美
    • 南美
    • 欧洲
    • 东亚
    • 南亚太地区
    • 中东及非洲
  • 各地区市场的魅力分析

第12章 北美的病人参与解决方案市场分析

第13章 南美的病人参与解决方案市场分析

第14章 欧洲的病人参与解决方案市场分析

第15章 南亚及太平洋地区的病人参与解决方案市场分析

第16章 东亚的病人参与解决方案市场分析

第17章 中东及非洲的病人参与解决方案市场分析

第18章 病人参与解决方案市场的主要国家分析

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 德国
  • 义大利
  • 法国
  • 英国
  • 西班牙
  • 荷比卢三国
  • 俄罗斯
  • 其他欧洲
  • 中国
  • 日本
  • 韩国
  • 印度
  • 马来西亚
  • 印尼
  • 新加坡
  • 澳洲和纽西兰
  • GCC各国
  • 土耳其
  • 南非
  • 其他中东及非洲

第19章 市场结构分析

  • 各级企业市场分析
  • 主要企业的市场占有率分析
  • 市场影响分析

第20章 竞争分析

  • 竞争仪表板
  • 竞争基准
  • 竞争详细内容
    • Allscripts Healthcare Solutions
    • Mckesson Corporation
    • Cerner Corporation
    • Phytel Inc
    • Medecision Inc
    • Athenahealth Inc
    • Novartis
    • Roche Holding AG
    • Bayer
    • GlaxoSmithkline
    • IQVIA

第21章 所使用的前提条件与缩写

第22章 调查手法

简介目录
Product Code: PMRREP4221

Persistence Market Research has recently published an extensive report on the global Patient Engagement Solution Market. This report provides an in-depth analysis of essential market dynamics, including drivers, trends, opportunities, and challenges, offering valuable insights into the market landscape.

Key Insights:

  • Patient Engagement Solution Market Size (2024E): USD 21.3 Bn
  • Projected Market Value (2033F): USD 50.7 Bn
  • Global Market Growth Rate (CAGR 2024 to 2033): 13.2%

Patient Engagement Solution Market - Report Scope:

Patient engagement solutions represent a significant advancement in healthcare, focusing on improving patient participation in their own care. These solutions encompass a range of tools and technologies designed to facilitate communication between patients and healthcare providers, enhance patient education, and improve overall healthcare outcomes. The market includes platforms such as patient portals, mobile health apps, and remote monitoring systems. The growth of the patient engagement market is driven by the increasing emphasis on patient-centered care, advancements in digital health technologies, and the need for improved healthcare outcomes.

Market Growth Drivers:

The global patient engagement solution market is driven by several key factors, including the rising demand for personalized and patient-centered healthcare services. Technological advancements in digital health, such as telemedicine, mobile health applications, and wearable devices, are enhancing patient engagement and driving market expansion. Increased focus on chronic disease management and preventive care is also contributing to market growth, as these solutions enable better monitoring and management of health conditions. Additionally, supportive government initiatives and healthcare reforms aimed at improving patient care and outcomes are further propelling the adoption of patient engagement solutions.

Market Restraints:

Despite its growth potential, the patient engagement solution market faces challenges related to data security, privacy concerns, and technological integration. Ensuring the security and privacy of patient data is crucial for maintaining trust and compliance with regulations such as HIPAA. The integration of patient engagement solutions with existing healthcare systems can be complex and costly, posing a challenge for healthcare providers. Additionally, disparities in digital health literacy and access to technology among different patient populations may hinder the widespread adoption of these solutions.

Market Opportunities:

The patient engagement solution market offers substantial growth opportunities driven by technological innovations and evolving healthcare models. The integration of artificial intelligence (AI) and machine learning into patient engagement platforms can enhance personalized care and predictive analytics. Opportunities also exist in expanding these solutions to underserved and rural areas, where access to healthcare services may be limited. Strategic partnerships between technology providers, healthcare organizations, and payers can create new business models and drive market growth. Additionally, the growing focus on value-based care and patient satisfaction presents opportunities for developing innovative patient engagement solutions.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the patient engagement solution market globally?
  • Which types of patient engagement solutions are gaining traction in different regions?
  • How are technological advancements reshaping the competitive landscape of the patient engagement market?
  • Who are the key players contributing to the patient engagement solution market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global patient engagement solution market?

Competitive Intelligence and Business Strategy:

Key players in the global patient engagement solution market, including companies such as Cerner Corporation, Allscripts Healthcare Solutions, and Medisafe, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced patient engagement tools, enhance interoperability with existing healthcare systems, and improve user experience. Collaborations with healthcare providers, technology firms, and regulatory bodies are essential to drive market adoption and address emerging needs. Additionally, a focus on data security, integration capabilities, and customer support helps to foster market growth and ensure the successful implementation of patient engagement solutions.

Key Companies Profiled:

  • Allscripts Healthcare Solutions
  • Mckesson Corporation
  • Cerner Corporation
  • Phytel Inc
  • Medecision Inc
  • Athenahealth Inc
  • Novartis
  • Roche Holding AG
  • Bayer
  • GlaxoSmithkline
  • IQVIA

Key Segments of Patient Engagement Solution Market Industry Research

By Solution:

  • Software
  • Services

By Deployment:

  • Cloud
  • On Premise

By Application:

  • Health Management
  • Social Management
  • Home Healthcare Management
  • Financial Health Management

By End User:

  • Patients
  • Payers
  • Healthcare Providers

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia Pacific
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Pricing Analysis

  • 4.1. Pricing Analysis, By Solution
    • 4.1.1. Subscription Pricing Model
    • 4.1.2. Perpetual Licensing
  • 4.2. Average Pricing Analysis Benchmark

5. Global Patient Engagement Solution Market Demand (in Value in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

  • 5.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
  • 5.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
    • 5.2.1. Y-o-Y Growth Trend Analysis
    • 5.2.2. Absolute $ Opportunity Analysis

6. Market Background

  • 6.1. Macro-Economic Factors
  • 6.2. Forecast Factors - Relevance & Impact
  • 6.3. Value Chain
  • 6.4. COVID-19 Crisis - Impact Assessment
    • 6.4.1. Current Statistics
    • 6.4.2. Short-Mid-Long Term Outlook
    • 6.4.3. Likely Rebound
  • 6.5. Market Dynamics
    • 6.5.1. Drivers
    • 6.5.2. Restraints
    • 6.5.3. Opportunities

7. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Solution

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size (US$ Bn) Analysis By Solution, 2019-2023
  • 7.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Solution, 2024-2033
    • 7.3.1. Software
      • 7.3.1.1. Integrated Patient Engagement Software
      • 7.3.1.2. Standalone Software
        • 7.3.1.2.1. Scheduling Software
        • 7.3.1.2.2. Billing Software
        • 7.3.1.2.3. Secure Messaging Software
        • 7.3.1.2.4. Others
    • 7.3.2. Services
      • 7.3.2.1. Implementation and Integration
      • 7.3.2.2. Consulting
      • 7.3.2.3. Support and Maintenance
  • 7.4. Market Attractiveness Analysis By Solution

8. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Deployment

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Bn) Analysis By Deployment, 2019-2023
  • 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Deployment, 2024-2033
    • 8.3.1. Cloud
    • 8.3.2. On-Premise
  • 8.4. Market Attractiveness Analysis By Deployment

9. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By Application

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
  • 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
    • 9.3.1. Health Management
    • 9.3.2. Social Management
    • 9.3.3. Home Healthcare Management
    • 9.3.4. Financial Health Management
    • 9.3.5. Others
  • 9.4. Market Attractiveness Analysis By Application

10. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By End User

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
  • 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
    • 10.3.1. Patients
    • 10.3.2. Payers
    • 10.3.3. Healthcare Providers
    • 10.3.4. Others
  • 10.4. Market Attractiveness Analysis By End User

11. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Region

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
  • 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
    • 11.3.1. North America
    • 11.3.2. Latin America
    • 11.3.3. Europe
    • 11.3.4. East Asia
    • 11.3.5. South Asia Pacific
    • 11.3.6. Middle East and Africa
  • 11.4. Market Attractiveness Analysis By Region

12. North America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 12.1. Introduction
  • 12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 12.3.1. By Solution
    • 12.3.2. By Deployment
    • 12.3.3. By Application
    • 12.3.4. By End User
    • 12.3.5. By Country
      • 12.3.5.1. U.S.
      • 12.3.5.2. Canada
  • 12.4. Market Attractiveness Analysis
    • 12.4.1. By Solution
    • 12.4.2. By Deployment
    • 12.4.3. By Application
    • 12.4.4. By End User
    • 12.4.5. By Country
  • 12.5. Market Trends
  • 12.6. Key Market Participants - Intensity Mapping

13. Latin America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 13.3.1. By Solution
    • 13.3.2. By Deployment
    • 13.3.3. By Application
    • 13.3.4. By End User
    • 13.3.5. By Country
      • 13.3.5.1. Brazil
      • 13.3.5.2. Mexico
      • 13.3.5.3. Rest of Latin America
  • 13.4. Market Attractiveness Analysis
    • 13.4.1. By Solution
    • 13.4.2. By Deployment
    • 13.4.3. By Application
    • 13.4.4. By End User
    • 13.4.5. By Country

14. Europe Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 14.3.1. By Solution
    • 14.3.2. By Deployment
    • 14.3.3. By Application
    • 14.3.4. By End User
    • 14.3.5. By Country
      • 14.3.5.1. Germany
      • 14.3.5.2. Italy
      • 14.3.5.3. France
      • 14.3.5.4. U.K.
      • 14.3.5.5. Spain
      • 14.3.5.6. BENELUX
      • 14.3.5.7. Russia
      • 14.3.5.8. Rest of Europe
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Solution
    • 14.4.2. By Deployment
    • 14.4.3. By Application
    • 14.4.4. By End User
    • 14.4.5. By Country

15. South Asia & Pacific Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 15.3.1. By Solution
    • 15.3.2. By Deployment
    • 15.3.3. By Application
    • 15.3.4. By End User
    • 15.3.5. By Country
      • 15.3.5.1. India
      • 15.3.5.2. Indonesia
      • 15.3.5.3. Malaysia
      • 15.3.5.4. Singapore
      • 15.3.5.5. Australia & New Zealand
      • 15.3.5.6. Rest of South Asia and Pacific
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Solution
    • 15.4.2. By Deployment
    • 15.4.3. By Application
    • 15.4.4. By End User
    • 15.4.5. By Country

16. East Asia Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 16.3.1. By Solution
    • 16.3.2. By Deployment
    • 16.3.3. By Application
    • 16.3.4. By End User
    • 16.3.5. By Country
      • 16.3.5.1. China
      • 16.3.5.2. Japan
      • 16.3.5.3. South Korea
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Solution
    • 16.4.2. By Deployment
    • 16.4.3. By Application
    • 16.4.4. By End User
    • 16.4.5. By Country

17. Middle East and Africa Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
  • 17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
    • 17.3.1. By Solution
    • 17.3.2. By Deployment
    • 17.3.3. By Application
    • 17.3.4. By End User
    • 17.3.5. By Country
      • 17.3.5.1. GCC Countries
      • 17.3.5.2. Turkey
      • 17.3.5.3. South Africa
      • 17.3.5.4. Rest of Middle East and Africa
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Solution
    • 17.4.2. By Deployment
    • 17.4.3. By Application
    • 17.4.4. By End User
    • 17.4.5. By Country

18. Key Countries Analysis- Patient Engagement Solution Market

  • 18.1. U.S. Patient Engagement Solution Market Analysis
    • 18.1.1. By Solution
    • 18.1.2. By Deployment
    • 18.1.3. By Application
    • 18.1.4. By End User
  • 18.2. Canada Patient Engagement Solution Market Analysis
    • 18.2.1. By Solution
    • 18.2.2. By Deployment
    • 18.2.3. By Application
    • 18.2.4. By End User
  • 18.3. Mexico Patient Engagement Solution Market Analysis
    • 18.3.1. By Solution
    • 18.3.2. By Deployment
    • 18.3.3. By Application
    • 18.3.4. By End User
  • 18.4. Brazil Patient Engagement Solution Market Analysis
    • 18.4.1. By Solution
    • 18.4.2. By Deployment
    • 18.4.3. By Application
    • 18.4.4. By End User
  • 18.5. Germany Patient Engagement Solution Market Analysis
    • 18.5.1. By Solution
    • 18.5.2. By Deployment
    • 18.5.3. By Application
    • 18.5.4. By End User
  • 18.6. Italy Patient Engagement Solution Market Analysis
    • 18.6.1. By Solution
    • 18.6.2. By Deployment
    • 18.6.3. By Application
    • 18.6.4. By End User
  • 18.7. France Patient Engagement Solution Market Analysis
    • 18.7.1. By Solution
    • 18.7.2. By Deployment
    • 18.7.3. By Application
    • 18.7.4. By End User
  • 18.8. U.K. Patient Engagement Solution Market Analysis
    • 18.8.1. By Solution
    • 18.8.2. By Deployment
    • 18.8.3. By Application
    • 18.8.4. By End User
  • 18.9. Spain Patient Engagement Solution Market Analysis
    • 18.9.1. By Solution
    • 18.9.2. By Deployment
    • 18.9.3. By Application
    • 18.9.4. By End User
  • 18.10. BENELUX Patient Engagement Solution Market Analysis
    • 18.10.1. By Solution
    • 18.10.2. By Deployment
    • 18.10.3. By Application
    • 18.10.4. By End User
  • 18.11. Russia Patient Engagement Solution Market Analysis
    • 18.11.1. By Solution
    • 18.11.2. By Deployment
    • 18.11.3. By Application
    • 18.11.4. By End User
  • 18.12. Rest of Europe Patient Engagement Solution Market Analysis
    • 18.12.1. By Solution
    • 18.12.2. By Deployment
    • 18.12.3. By Application
    • 18.12.4. By End User
  • 18.13. China Patient Engagement Solution Market Analysis
    • 18.13.1. By Solution
    • 18.13.2. By Deployment
    • 18.13.3. By Application
    • 18.13.4. By End User
  • 18.14. Japan Patient Engagement Solution Market Analysis
    • 18.14.1. By Solution
    • 18.14.2. By Deployment
    • 18.14.3. By Application
    • 18.14.4. By End User
  • 18.15. South Korea Patient Engagement Solution Market Analysis
    • 18.15.1. By Solution
    • 18.15.2. By Deployment
    • 18.15.3. By Application
    • 18.15.4. By End User
  • 18.16. India Patient Engagement Solution Market Analysis
    • 18.16.1. By Solution
    • 18.16.2. By Deployment
    • 18.16.3. By Application
    • 18.16.4. By End User
  • 18.17. Malaysia Patient Engagement Solution Market Analysis
    • 18.17.1. By Solution
    • 18.17.2. By Deployment
    • 18.17.3. By Application
    • 18.17.4. By End User
  • 18.18. Indonesia Patient Engagement Solution Market Analysis
    • 18.18.1. By Solution
    • 18.18.2. By Deployment
    • 18.18.3. By Application
    • 18.18.4. By End User
  • 18.19. Singapore Patient Engagement Solution Market Analysis
    • 18.19.1. By Solution
    • 18.19.2. By Deployment
    • 18.19.3. By Application
    • 18.19.4. By End User
  • 18.20. Australia and New Zealand Patient Engagement Solution Market Analysis
    • 18.20.1. By Solution
    • 18.20.2. By Deployment
    • 18.20.3. By Application
    • 18.20.4. By End User
  • 18.21. GCC Countries Patient Engagement Solution Market Analysis
    • 18.21.1. By Solution
    • 18.21.2. By Deployment
    • 18.21.3. By Application
    • 18.21.4. By End User
  • 18.22. Turkey Patient Engagement Solution Market Analysis
    • 18.22.1. By Solution
    • 18.22.2. By Deployment
    • 18.22.3. By Application
    • 18.22.4. By End User
  • 18.23. South Africa Patient Engagement Solution Market Analysis
    • 18.23.1. By Solution
    • 18.23.2. By Deployment
    • 18.23.3. By Application
    • 18.23.4. By End User
  • 18.24. Rest of Middle East and Africa Patient Engagement Solution Market Analysis
    • 18.24.1. By Solution
    • 18.24.2. By Deployment
    • 18.24.3. By Application
    • 18.24.4. By End User

19. Market Structure Analysis

  • 19.1. Market Analysis by Tier of Companies
  • 19.2. Market Share Analysis of Top Players
  • 19.3. Market Presence Analysis

20. Competition Analysis

  • 20.1. Competition Dashboard
  • 20.2. Competition Benchmarking
  • 20.3. Competition Deep Dive
    • 20.3.1. Allscripts Healthcare Solutions
      • 20.3.1.1. Business Overview
      • 20.3.1.2. Product Portfolio
      • 20.3.1.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.1.4. Key Strategy & Developments
    • 20.3.2. Mckesson Corporation
      • 20.3.2.1. Business Overview
      • 20.3.2.2. Product Portfolio
      • 20.3.2.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.2.4. Key Strategy & Developments
    • 20.3.3. Cerner Corporation
      • 20.3.3.1. Business Overview
      • 20.3.3.2. Product Portfolio
      • 20.3.3.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.3.4. Key Strategy & Developments
    • 20.3.4. Phytel Inc
      • 20.3.4.1. Business Overview
      • 20.3.4.2. Product Portfolio
      • 20.3.4.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.4.4. Key Strategy & Developments
    • 20.3.5. Medecision Inc
      • 20.3.5.1. Business Overview
      • 20.3.5.2. Product Portfolio
      • 20.3.5.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.5.4. Key Strategy & Developments
    • 20.3.6. Athenahealth Inc
      • 20.3.6.1. Business Overview
      • 20.3.6.2. Product Portfolio
      • 20.3.6.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.6.4. Key Strategy & Developments
    • 20.3.7. Novartis
      • 20.3.7.1. Business Overview
      • 20.3.7.2. Product Portfolio
      • 20.3.7.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.7.4. Key Strategy & Developments
    • 20.3.8. Roche Holding AG
      • 20.3.8.1. Business Overview
      • 20.3.8.2. Product Portfolio
      • 20.3.8.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.8.4. Key Strategy & Developments
    • 20.3.9. Bayer
      • 20.3.9.1. Business Overview
      • 20.3.9.2. Product Portfolio
      • 20.3.9.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.9.4. Key Strategy & Developments
    • 20.3.10. GlaxoSmithkline
      • 20.3.10.1. Business Overview
      • 20.3.10.2. Product Portfolio
      • 20.3.10.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.10.4. Key Strategy & Developments
    • 20.3.11. IQVIA
      • 20.3.11.1. Business Overview
      • 20.3.11.2. Product Portfolio
      • 20.3.11.3. Profitability by Market Segments (Business Segments/Region)
      • 20.3.11.4. Key Strategy & Developments

21. Assumptions and Acronyms Used

22. Research Methodology